OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 9 citing articles:

EASL recommendations on treatment of hepatitis C: Final update of the series☆
Jean‐Michel Pawlotsky, Francesco Negro, Alessio Aghemo, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 5, pp. 1170-1218
Closed Access | Times Cited: 974

Virological Factors Associated with Failure to the Latest Generation of Direct Acting Agents (DAA) and Re-Treatment Strategy: A Narrative Review
Lorenzo Onorato, Mariantonietta Pisaturo, Mario Starace, et al.
Viruses (2021) Vol. 13, Iss. 3, pp. 432-432
Open Access | Times Cited: 9

Screening, confirmation, and treatment rates of hepatitis C virus infection in a tertiary academic medical center in South Korea
Jae Seung Lee, Hong Jun Choi, Hye Won Lee, et al.
Journal of Gastroenterology and Hepatology (2021) Vol. 36, Iss. 9, pp. 2479-2485
Closed Access | Times Cited: 7

Natural prevalence of NS3 gene resistance-associated substitutions (RASs) in patients with chronic hepatitis C from the state of Pará/Brazil
Desirée Lopes da Silva, Heloísa Marceliano Nunes, Pedro Eduardo Bonfim Freitas
Virus Research (2020) Vol. 292, pp. 198251-198251
Closed Access | Times Cited: 6

Efficacy and safety of elbasvir/grazoprevir for 12 weeks in people with hepatitis C virus infection aged 35 years or younger compared with older people: a retrospective integrated analysis
Tarik Asselah, Stefan Zeuzem, Nancy Reau, et al.
Current Medical Research and Opinion (2020) Vol. 36, Iss. 8, pp. 1325-1332
Closed Access | Times Cited: 3

Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with or without glucose abnormalities: Results of the EGG18 study
V. Calvaruso, Salvatore Petta, Donatella Ferraro, et al.
Digestive and Liver Disease (2021) Vol. 54, Iss. 8, pp. 1117-1121
Open Access | Times Cited: 1

Regional experience in assessing medical technology on the example of antiviral therapy for chronic hepatitis C with direct antiviral drugs
Ekaterina B. Kornilova, Malwina Hołownia-Voloskova, E S Arkova, et al.
Health Care of the Russian Federation (2020) Vol. 64, Iss. 6, pp. 318-323
Open Access

Modern principles of etiotropic therapy for chronic hepatitis B and C
N.I. Kuznetsov, Irina Е. Moiseeva
Russian Family Doctor (2022) Vol. 26, Iss. 4, pp. 7-15
Closed Access

Current Management of Patients with HCV Genotype 1
Tarik Asselah, Patrick Marcellin
Springer eBooks (2021), pp. 75-82
Closed Access

Page 1

Scroll to top